Newer formulations are even more effective at preventing illnesses that commonly afflict seniors — perhaps even dementia.

The next time I care for a family that is finally ready to provide the COVID-19 vaccine to their child, I am not sure if they ...

Find insight on Riverstone Holdings, CSL’s vaccines business and more in the latest Market Talks covering Health Care.

Let's see what Bell Potter is saying about this blue chip. The post Why CSL shares could be a bargain buy at $240 appeared ...

Variant NB.1.8.1 accounted for 0% of U.S. cases in April. By mid-June, it was estimated to be the cause of around 37% of ...

Last week, the CDC's Advisory Committee on Immunization Practices (ACIP) discussed options to narrow recommendations for the fall COVID vaccine to include only adults and children at higher risk ...